Innate Pharma to hold its Annual General Meeting of shareholders on May 20, 2022
Innate Pharma files its 2021 Universal Registration Document (Document d'enregistrement universel) and 2021 Annual Report on Form 20-F
Innate Pharma reports Full Year 2021 financial results and business update
Innate Pharma announces conference call and webcast for Full Year 2021 financial results
Number of shares and voting rights of Innate Pharma as of March 1, 2022
Number of shares and voting rights of Innate Pharma as of February 1, 2022
Innate Pharma to participate in upcoming investor conferences
Number of shares and voting rights of Innate Pharma as of January 1, 2022
Innate Pharma obtains €28.7M in non-dilutive financing in the form of State Guaranteed Loans
Innate Pharma to participate in upcoming investor conferences
